Related Experiment Video
Updated: Aug 14, 2026
A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
Newborn screening guidelines for the critically ill infant
1Johns Hopkins University, USA. kbalk1@son.jhmi.edu
Insights
Newborn screening using mass spectrometry can detect metabolic diseases early. Special guidelines are needed for critically ill infants due to factors affecting test results, ensuring timely diagnosis and preventing severe outcomes.
Area of Science:
- Biochemistry
- Neonatal Medicine
- Medical Diagnostics
Background:
- Mass spectrometry enables early detection of metabolic diseases in newborns.
- Critically ill neonates require specific screening protocols due to confounding factors like aminoglycosides and blood transfusions.
- Early diagnosis of metabolic disorders is crucial for preventing severe, long-term health consequences.
Purpose of the Study:
- To highlight the need for specialized practice guidelines for newborn screening in neonatal intensive care units (NICUs).
- To address the lack of standardized protocols for notifying parents of positive newborn screening results.
- To emphasize the importance of timely follow-up care to prevent neurological sequelae.
Main Methods:
- Review of existing newborn screening practices and their limitations in critical care settings.
- Analysis of factors that can interfere with mass spectrometry-based newborn screening.
- Examination of current gaps in responsibility for parental notification and follow-up.
Main Results:
- Established newborn screening methods are affected by treatments common in NICUs.
- There is a lack of standardized guidelines for screening neonates receiving critical care.
- Responsibility for parental notification and ensuring follow-up care is not consistently defined.
Conclusions:
- Development of specific practice guidelines for NICU newborn screening is essential.
- Standardized protocols are needed to ensure accurate screening and timely intervention for at-risk neonates.
- Clear guidelines for parental notification and follow-up are critical to prevent adverse neurological outcomes.
Abstract:
The use of mass spectrometry in newborn screening has made possible the early diagnosis of various metabolic diseases. However, because aminoglycosides, blood transfusions, nothing by mouth status, and the presence of heparinized solutions all affect the results of newborn screens, neonates in critical care units who receive such treatments ought to be screened under specific practice guidelines. Many of the devastating sequelae of metabolic diseases are preventable if diagnosed early, making the development of such practice guidelines for use in the NICU especially important. Additionally, no standardized practice guidelines presently exist for determining who, whether birth hospital or primary care provider, is responsible for notifying the parent of a positive result and thus ensuring invaluable follow-up care. Such standardized guidelines for screening practice are needed to prevent devastating neurologic sequelae for children whose condition may otherwise escape unaddressed. Newborn screening guidelines developed at Johns Hopkins Hospital and Memorial Regional Hospital provide a helpful starting point.
